GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHO Pharma Inc (ROCO:6586) » Definitions » Other Long Term Assets

CHO Pharma (ROCO:6586) Other Long Term Assets : NT$2.66 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CHO Pharma Other Long Term Assets?

CHO Pharma's other long-term assets for the quarter that ended in Dec. 2024 was NT$2.66 Mil.

CHO Pharma's quarterly other long-term assets declined from Dec. 2023 (NT$3.02 Mil) to Jun. 2024 (NT$2.66 Mil) but then increased from Jun. 2024 (NT$2.66 Mil) to Dec. 2024 (NT$2.66 Mil).

CHO Pharma's annual other long-term assets declined from Dec. 2022 (NT$5.84 Mil) to Dec. 2023 (NT$3.02 Mil) and declined from Dec. 2023 (NT$3.02 Mil) to Dec. 2024 (NT$2.66 Mil).


CHO Pharma Other Long Term Assets Historical Data

The historical data trend for CHO Pharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHO Pharma Other Long Term Assets Chart

CHO Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.73 9.44 5.84 3.02 2.66

CHO Pharma Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.84 2.66 3.02 2.66 2.66

CHO Pharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


CHO Pharma Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 18F, Building F, Nangang, Taipei, TWN, 11503
CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.

CHO Pharma Headlines

No Headlines